FINWIRES · TerminalLIVE
FINWIRES

Ajinomoto's Profit Jumps 92% in Fiscal Year 2025

作者

-- Ajinomoto's (TYO:2802) profit attributable to owners of the parent surged 92% to 134.7 billion yen for the fiscal year 2025 from 70.3 billion yen a year earlier.

The food seasoning manufacturer's earnings per share increased to 138.36 yen from 69.77 yen a year ago, according to a Tokyo bourse filing on Thursday.

Sales jumped 3.5% to 1.584 trillion yen for the year ended March 31 from 1.531 trillion yen in the prior year.

It declared a final dividend of 24 yen per share, payable from June 22.

For the fiscal year 2026, the company expects attributable profit of 120 billion yen, basic EPS of 126.16 yen, and sales of 1.723 trillion yen.

Ajinomoto plans to pay interim and year-end dividends of 25 yen per share, each, for the year, which is higher than the amount paid in the year-ago period.

相关文章

Asia

周四印度股市收盘持平,盈利支撑抵消了疲软态势。

周四,印度基准股指基本持平,财报利好消息推动的上涨抵消了整体市场的疲软。 孟买证券交易所Sensex指数下跌114.00点,跌幅0.2%,收于77,844.52点;印度国家证券交易所Nifty 50指数下跌4.30点,跌幅0.02%,收于24,326.65点。 市场预期美伊紧张局势将有所缓和,进一步提振了投资者情绪。据报道,德黑兰正在重新评估美国旨在结束冲突的最新提议。 企业方面,印度巴拉特锻造公司(Bharat Forge,NSE:BHARATFORG,BOM:500493)公布,第四财季合并利润从上年同期的28.3亿卢比降至23.3亿卢比。然而,营业收入从170亿卢比增至203亿卢比。 根据一份文件显示,拉森特博洛公司(Larsen & Toubro,NSE:LT,BOM:500510)股价上涨,原因是其建筑和工厂业务从一家房地产客户处获得了三份大型订单,涉及三个邦的项目。该公司将金额在250亿卢比至500亿卢比之间的订单定义为大型订单。

$^BSE$^NSEI$BOM:500493$BOM:500510$NSE:BHARATFORG$NSE:LT
Asia

黑龙江中邦制药赢得中药项目竞标

据周四提交给上海证券交易所的文件显示,黑龙江中邦药业(SHA:603567)的两款产品在中国传统药品采购项目中中标。 文件称,这两款产品分别是中邦药业用于儿童的速效糖浆(适用于退烧和咽喉痛)以及用于治疗心绞痛或胸痛的向丹注射液。

$SHA:603567
Asia

凯德集团旗下腾飞房地产投资信托完成对日本数据中心的收购

根据周四提交给新加坡交易所的文件显示,凯德集团旗下腾飞房地产信托(CapitaLand Ascendas REIT,SGX:A17U)已完成对日本一家数据中心的收购。 文件称,此次收购的部分资金来自股权融资,募集资金总额约为9.035亿新元,其中约1.883亿新元用于部分融资。

$SGX:A17U